• Vk
  • LinkedIn
  • Youtube
X7 Research
  • News
  • Registration strategy and Сonsulting
    • Budgeting
    • Registration strategy development
    • Study feasibility
    • Vendor selection
    • Data search and analysis
  • Clinical trials
    • Outsourcing CRAs in Russia and the EAEU
    • Development of medical documentation and biostatistics
    • Monitoring
    • Data-management
    • Patient home visits
    • Bioequivalence study
    • Therapeutic equivalence studies
    • Clinical trials of medical devices
  • Registration
    • Audit of the registration dossier
    • Bringing the registration dossier in compliance with the requirements of the EAEU
    • Conversion of registration dossier into XML format
    • PIL readability user testing
    • Translation of the Registration dossier
    • Turnkey registration
  • Post-authorization clinical studies
    • Phase IV studies
    • Non-interventional studies
    • Investigator-initiated studies
    • Post-authorisation safety study
    • Marketing research
  • Pharmacovigilance
    • QPPV in the EAEU
    • Safety monitoring of medical devices
    • Building a pharmacovigilance system
    • Safety in clinical trials
    • Pharmacovigilance audit
    • Pharmacovigilance contact person
  • Therapeutic expertise
    • Clinical trials in Oncology in the EAEU
  • Contact
  • EnglishEnglish
  • Menu

Russian Roszdravnadzor and Ministry of Health participate in international medicinal products development actively

17.03.2017/in News /by ValeriiaKirienko

Harmonization is essential for pharmaceutical industry. Basic players capture the market which results into globalization. Expansion happens in all countries, not only in countries these companies originate from. Regulatory revolution reflects market trends nowadays. Nine out of ten pharmaceutical companies that have the highest market share in Russia are foreign, according to published data for Dec 2016 and Jan 2017. Consequently, governmental expert organizations in Russia cooperate close with international organizations.

World Health Organization (WHO) offered to Centre of Pharmacopoeia and International Cooperation, a subdivision of Russian Scientific Centre for Expert Evaluation of Medicinal Products’ (“SCEEMP”) to take part in Good Pharmacopoeial Practice guidance development.

WHO Good Pharmacopoeial Practice guidance is intended to help diverse international pharmacopeias to cooperate in the development of their own national standards. Such cooperation will make sure that harmonization does not obstruct market growth but promotes the implementation of new approaches to local practice. This step is a consequential continuation of well-established collaboration. Recently WHO recognized seven “SCEEMP” laboratories as conforming to international quality standards.

Cooperation between Russian expert organizations and international institutions is a general trend today. This March Krasnoyarsk subdivision of Federal State Budgetary Institution “Information and Methodological Center for Expert Evaluation, Recording and Analysis of Circulation of Medical Products” has been internationally recognized and included into European network of official medicines control laboratories (OMCL). Quality control harmonization will essentially happen and as the result, long-lasting and durable information exchange will be developed between Russian Rosdravnadzor laboratory and more than 70 laboratories from 40 countries worldwide.

New guidance on Good Pharmacopoeial Practice is going to be published by the end of 2017. Once new approach will be implemented, access to medicinal products with the proper quality for the public will be expanded. Consequently, it will promote a new path for pharmaceutical industry development. Furthermore, mutual recognition of tests throughout OMCL laboratories will provide proper vigilance for medicines. Such evolution is beneficial for all market participants- pharmaceutical industry, regulators and Russian society

Sources:

http://dsm.ru/docs/analytics/january_2017_pharmacy_analysis.pdf

http://www.roszdravnadzor.ru/news/6430

http://www.regmed.ru/Content/News/PressRelease_20170307_WHO-GPhP

https://www.edqm.eu/en/general-european-omcl-network-geon

Share this entry
  • Share on Twitter
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail

YOU MAY ALSO BE INTERESTED IN

Publications
Readability User Testing of Package Information Leaflets (PIL) in EAEU
Read More
Publications
Remote clinical trial monitoring
Read More
Publications
Post-authorization studies of drug safety in Russia
Read More

RUBRICS

Registration strategy and Сonsulting

Clinical trials

Registration

Post-authorization clinical studies

Pharmacovigilance

LATEST PUBLICATIONS

  • Corrections to clinical trial documents due to COVID-19. Russian experience.
  • WHAT IS BIOEQUIVALENCE
  • THE VOLUME OF RUSSIAN PHARMACEUTICAL MARKET 2016-2019

Tags

bioequivalenceClinical trials in the CISfeasibilitymonitoringRadiopharmaceuticals

CONTACT

2 + 2 = ?

This contact form is deactivated because you refused to accept Google reCaptcha service which is necessary to validate any messages sent by the form.

PRIVACY

Use of this site constitutes your consent to our Privacy Policy.


SOCIAL RESPONSIBILITY

X7 Research’s primary responsibility is to help our clients in bringing medicines & products to the market efficiently and safely.

The Best CRO for Clinical Trials | Full-service Global CRO — X7 Research

The Best CRO in Pharma | Clinical Research Organisation — X7 Research

The Best Contract Research Organisation (CRO) | Trusted CRO — X7 Research

The Best Clinical Research Organisation (CRO): Full Service CRO | X7 Research

The Best CRO in Research | Trusted CRO for Your Trail — X7 Research

The Best Clinical Trial Company | Global Full-service CRO - X7 Research

The Best Pharma CROs: Clinical Trials for Drugs | X7 Research

The Best CROs Company: Clinical Trials with Global CRO — X7 Research

The Best Pre-clinical CRO: Safety Assessment With X7 Research

The Best Clinical Development | Trusted CRO for Your Product: X7 Research

The Best Biostatistical Consulting: Statistical Services | X7 Research

The Best Pharmacovigilance Consulting Services | CRO — X7 Research

Feasibility in Clinical Trials: What is a Feasibility in Clinical Trials?

Clinical Study Trials: What are Clinical Study Trials?

Category
Strategy and consulting
Clinical trials
Registration
Post-authorization clinical studies
Pharmacovigilance

Registration strategy and Сonsulting
Registration strategy development
Budgeting
Study feasibility
Vendor selection
Data search and analysis

Clinical trials
Development of medical documentation and biostatistics
Monitoring
Data management
Patient home visits
Bioequivalence study
Therapeutic equivalence studies

Registration
Audit of the registration dossier
Dossier eaeu
Conversion of registration dossier into xml format
Pil readability user testing
Turnkey registration

Post-authorization clinical studies
Phase iv studies
Non interventional studies
Investigator initiated studies
Post authorisation safety study
Marketing research

Pharmacovigilance
Building a pharmacovigilance system
Safety in clinical trials
Pharmacovigilance audit
Pharmacovigilance contact person

Blog
Contacts

© Copyright 2010-2023 - X7 Research. All rights reserved.
Clinical Research and Modern Gadgets Cellular products in Russia: where we stand?
Scroll to top